Clinical & Experimental Metastasis

, Volume 19, Issue 4, pp 319–326 | Cite as

Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

  • Weiguo Wu
  • Ximing Tang
  • Wei Hu
  • Reuben Lotan
  • Waun Ki Hong
  • Li Mao


Despite improvements in treatment of patients with head and neck squamous cell carcinoma (HNSCC) over the last two decades, the survival rate of these patients has not increased significantly. One of the major factors in the poor outcome of the disease is regional metastasis. To better understand the mechanisms of this process at the protein level, we performed two-dimensional electrophoresis (2-DE) and mass spectrometry using SELDI ProteinChip technology to identify proteins differentially expressed in two HNSCC cell lines, UMSCC10A and UMSCC10B, from the same patient. UMSCC10A was derived from the primary tumor and UMSCC10B from a metastatic lymph node. The differentially expressed proteins were excised from the gels. Following in-gel digestion by trypsin, mass profiles of the peptides were generated. Proteins were identified by submitting the peptide mass profiles to a public available NCBInr databases ( Two membrane-associated proteins, annexin I and annexin II, and glycolytic protein enolase-α were found to be upregulated, and calumenin precursor down-regulated, in metastatic cell line UMSCC10B. The identity of these proteins was confirmed by analyzing additional peptide mass fingerprints obtained by endoproteinase lysine-C digestion. The results were also validated by Western blotting analysis. Our results showed that enolase-α, annexin-I and annexin-II might be important molecules in head and neck cancer invasion and metastasis. The results also suggest an important complementary role for proteomics in identification of molecular abnormalities important in cancer development and progression.

HNSCC metastasis two-dimensional electrophoresis mass spectrometry 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Greenlee RT, Murray T, Bolden S et al. Wingo PS. Cancer Statistics, 2000. CA Cancer J Clin2000;50:7–33.PubMedGoogle Scholar
  2. 2.
    Pandey A, Mann M. Proteomics to study genes and genomes (Review). Nature 2000;405(6788):837–46.PubMedCrossRefGoogle Scholar
  3. 3.
    Alaiya AA, Franzen B, Auer G et al. Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification (Review).Electrophoresis2000;21(6): 1210–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Dutt MJ, Lee KH. Proteomic analysis(Review).Curr Opin Biotechnol. 2000;11(2):176–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Lahm HW, Langen H.Mass spectrometry: A tool for the identification of proteins separated by gels (Review).Electrophoresis2000;21(11): 1210–7.CrossRefGoogle Scholar
  6. 6.
    Celis JE, Celis P, Ostergaard M et al. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.Cancer Res1999;59(12):3003–9.PubMedGoogle Scholar
  7. 7.
    Ostergaard M, Wolf H, Orntoft TF et al.Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas.Electrophoresis1999;20(2):349–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Celis JE, Wolf H, Ostergaard M. Bladder squamous cell carcinoma biomarkers derived from proteomics.Electrophoresis2000;21(11): 2115–21.PubMedCrossRefGoogle Scholar
  9. 9.
    Page MJ, Amess B, Townsend RR et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.Proc Natl Acad Sci USA1999;96(22): 12589–94.PubMedCrossRefGoogle Scholar
  10. 10.
    Sarto C, Marocchi A, Sanchez JC et al. Renal cell carcinoma and normal kidney protein expression.Electrophoresis1997;18(3–4): 599–604.PubMedCrossRefGoogle Scholar
  11. 11.
    Franzen B, Linder S, Alaiya AA et al. Analysis of polypeptide expression in benign and malignant human breast lesions: Down-regulation of cytokeratins.Br J Cancer1996;74(10):1632–8.PubMedGoogle Scholar
  12. 12.
    Chuman Y, Bergman A, Ueno T et al. Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.FEBS Lett 1999;462(1–2):129–134.PubMedCrossRefGoogle Scholar
  13. 13.
    Alaiya AA, Franzén B, Moberger B Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity.Electrophoresis1999;20(4–5):1039–46.PubMedCrossRefGoogle Scholar
  14. 14.
    Von Eggeling F, Davies H, Lomas L et al. Tissue-specific microdissection coupled with ProteinChip array technologies: Applications in cancer research.BioTechniques2000;29:1066–70.PubMedGoogle Scholar
  15. 15.
    Neuhoff V, Arold N, Taube D et al. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250.Electrophoresis1988;9:255–62.PubMedCrossRefGoogle Scholar
  16. 16.
    Moss SE. The Annexins.London: Portland Press 1992;1–10.Google Scholar
  17. 17.
    Raynal P, Pollard HB. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins.Biochim Biophys Acta1994;1197(1): 63–93.PubMedGoogle Scholar
  18. 18.
    Rhee HJ, Kim GY, Huh JW et al. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent.Eur J Biochem 2000;267(11):3220–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Benz J, Hofmann A. Annexins: From structure to function.Biol Chem 1997;378(3–4):177–83.PubMedGoogle Scholar
  20. 20.
    Pencil SD, Toh Y, Nicolson GL. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma.Breast Cancer Res Treat1993;25(2):165–74.PubMedCrossRefGoogle Scholar
  21. 21.
    Pencil SD, Toth M. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma.Clin Exp Metastasis1998; 16(2):113–21.PubMedCrossRefGoogle Scholar
  22. 22.
    Sinha P, Hutter G, Kottgen E et al. Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug-resistant human stomach cancer cells.J Biochem Biophys Methods1998;37(3):105–16.PubMedCrossRefGoogle Scholar
  23. 23.
    Koseki H, Shiiba K, Suzuki Y et al. Enhanced expression of lipocortin-1 as a new immunosuppressive protein in cancer patients and its influence on reduced in vitro peripheral blood lymphocyte response to mitogens.Surg Today1997;27(1):30–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Mai J, Waisman DM, Sloane BF. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.Biochim Biophys Acta2000;1477(1–2):215–30.PubMedGoogle Scholar
  25. 25.
    Hajjar KA, Acharya SS. Annexin II and regulation of cell surface fibrinolysis.Ann NY Acad Sci2000;902:265–71.PubMedCrossRefGoogle Scholar
  26. 26.
    Siever DA, Erickson HP. Extracellular annexin II.Int J Biochem Cell Biol1997;29(11):1219–23.PubMedCrossRefGoogle Scholar
  27. 27.
    Mai J, Finley RL Jr, Waisman DM et al. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells.J Biol Chem2000; 275(17):12806–12.PubMedCrossRefGoogle Scholar
  28. 28.
    Fitzpatrick SL, Kassam G, Choi KS et al. Regulation of plasmin activity by annexin II tetramer.Biochemistry2000;39(5):1021–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Kassam G, Choi KS, Ghuman J et al. Waisman DM. The role of annexin II tetramer in the activation of plasminogen. J Biol Chem1998; 273(8):4790–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Hajjar KA, Krishnan S. Annexin II: A mediator of the plasmin/ plasminogen activator system.Trends Cardiovasc Med 1999; 9(5):128–38.PubMedCrossRefGoogle Scholar
  31. 31.
    Kang HM, Choi KS, Kassam G et al.Role of annexin II tetramer in plasminogen activation.Trends Cardiovasc Med 1999;9(3–4):92–102.PubMedCrossRefGoogle Scholar
  32. 32.
    Paciucci R, Tora M, Diaz VM et al. The plasminogen activator system in pancreas cancer: Role of t-PA in the invasive potential in vitro. Oncogene1998;16(5):625–33.PubMedCrossRefGoogle Scholar
  33. 33.
    Vishwanatha JK, Chiang Y, Kumble KD et al. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers.Carcinogenesis 1993;14(12):2575–9.PubMedGoogle Scholar
  34. 34.
    Yeatman TJ, Updyke TV, Kaetzel MA et al. Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells.Clin Exp Metastasis1993; 11(1):37–44.PubMedCrossRefGoogle Scholar
  35. 35.
    Choi KS, Ghuman J, Kassam G et al. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.Biochemistry1998;37(2):648–55.PubMedCrossRefGoogle Scholar
  36. 36.
    Wirl G, Schwartz-Albiez R. Collagen-binding proteins of mammary epithelial cells are related to Ca2(+)-and phospholipid-binding annexins.J Cell Physiol1990; 144(3):511–22.PubMedCrossRefGoogle Scholar
  37. 37.
    Chung CY, Erickson HP. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.J Cell Biol1994;126(2):539–48.PubMedCrossRefGoogle Scholar
  38. 38.
    Kassam G, Le BH, Choi KS et al. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.Biochemistry1998;37(48):16958–66.PubMedCrossRefGoogle Scholar
  39. 39.
    Jost M, Gerke V. Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochim Biophys Acta1996; 1313(3):283–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Semenza GL, Jiang BH, Leung SW et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996;271(51):32529–37.PubMedCrossRefGoogle Scholar
  41. 41.
    Minet E, Michel G, Remacle J et al. Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (Review).Int J Mol Med.2000; 5(3):253–9.PubMedGoogle Scholar
  42. 42.
    Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.Cancer Res1999; 59(22):5830–5.PubMedGoogle Scholar
  43. 43.
    Redlitz A, Fowler BJ, Plow EF et al. The role of an enolase-related molecule in plasminogen binding to cells.Eur J Biochem1995; 227(1–2):407–15.PubMedCrossRefGoogle Scholar
  44. 44.
    Miles LA, Dahlberg CM, Plescia J et al. Role of cell-surface lysines in plasminogen binding to cells: Identification of alpha-enolase as a candidate plasminogen receptor.Biochemistry 1991;30(6):1682–91.PubMedCrossRefGoogle Scholar
  45. 45.
    Honore B, Vorum H. The CREC family, a novel family of multiple EFhand, low-affinity Ca(2+)-binding proteins localized to the secretory pathway of mammalian cells.FEBS Lett2000;466(1):11–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Liu Z, Brattain MG, Appert H. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7.Biochem Biophys Res Commun1997;231(2): 283–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Chen JJ, Reid CE, Band V et al. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.Science 1995; 269(5223): 529–31.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Weiguo Wu
    • 1
  • Ximing Tang
    • 1
  • Wei Hu
    • 2
  • Reuben Lotan
    • 1
  • Waun Ki Hong
    • 1
  • Li Mao
    • 1
  1. 1.Department of Thoracic/Head and Neck Medical Oncology, TheUniversity of TexasHoustonUSA
  2. 2.Department of Gynecologic and Medical OncologyThe University of TexasHoustonUSA

Personalised recommendations